Koers CaliPharms, Inc. Other OTC
Aandelen
KGET
US4984561021
Farmaceutische producten
Omzet 2012 | - | Omzet 2013 | - | Marktkapitalisatie | 8,23 mln. 7,67 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2012 | - 0 | Nettowinst (verlies) 2013 | - 0 | EV/omzet 2012 * | - |
Nettoschuld 2012 | 617K 575K | Nettoschuld 2013 | 667K 622K | EV/omzet 2013 | - |
K/w-verhouding 2012 * |
-
| K/w-verhouding 2013 |
-0,51
x | Werknemers | - |
Dividendrendement 2012 * |
-
| Dividendrendement 2013 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,33% | 6,11 mld. | |
-18,38% | 4,35 mld. | |
-9,17% | 3,18 mld. | |
+3,98% | 3,16 mld. | |
-3,41% | 2,51 mld. | |
+48,74% | 1,98 mld. | |
-4,82% | 1,74 mld. | |
-1,24% | 1,63 mld. | |
-8,96% | 1,6 mld. |